🇺🇸 FDA
Patent

US 7214687

Quinuclidine derivatives and medicinal compositions containing the same

granted A61KA61K31/439A61K31/4745

Quick answer

US patent 7214687 (Quinuclidine derivatives and medicinal compositions containing the same) held by ALMIRALL, LLC expires Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ALMIRALL, LLC
Grant date
Tue May 08 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/439, A61K31/4745, A61K31/56, A61K45/06